Tetra Bio-Pharma Inc. Announces a Non-Brokered Private Placement
OTTAWA, ONTARIO–(Marketwired – March 16, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in […]
Zargon Oil & Gas Ltd. Provides 2017 Fourth Quarter and Full Year Financial Results
CALGARY, Alberta, March 15, 2018 (GLOBE NEWSWIRE) — Zargon Oil & Gas Ltd. (“Zargon” or the “Company”) (TSX:ZAR) (TSX:ZAR.DB.A) has released […]
Mason Graphite Announces the Appointment of Two New Members to its Board of Directors
MONTREAL, QUEBEC–(Marketwired – March 15, 2018) – Mason Graphite Inc. (“Mason Graphite” or the “Company”) (TSX VENTURE:LLG)(OTCQX:MGPHF) is pleased to [...]
Engagement Labs Renews Contract With Leading US Telecom; Grows Annual Contract Size by 100%
MONTREAL, QC and NEW BRUNSWICK, NJ–(Marketwired – March 15, 2018) – Engagement Labs (TSX VENTURE: EL) (OTCQB: ELBSF) announced today […]
Knight Reports 2017 Fourth Quarter and Year End Results
MONTREAL, QUEBEC–(Marketwired – March 15, 2018) – Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, today reported [...]
Engagement Labs Renews Contract With Leading US Telecom; Grows Annual Contract Size by 100%
MONTREAL, QC and NEW BRUNSWICK, NJ–(Marketwired – March 14, 2018) – Engagement Labs (TSX VENTURE: EL) (OTCQB: ELBSF) announced today […]
Vior Discovers a New Gold Zone North of the Kiask River Fault on Mosseau, Lebel-Sur-Quevillon, Quebec
QUEBEC CITY, QUEBEC–(Marketwired – March 14, 2018) – SOCIÉTÉ D’EXPLORATION MINIÈRE VIOR INC. (TSX VENTURE:VIO)(FRANKFURT:VL51) (“Vior” or the [...]
Silver Spruce Receives Second Round of Assays from Kay Mine Development Rock Sampling, Arizona, USA
BRIDGEWATER, NOVA SCOTIA–(Marketwired – March 14, 2018) – Silver Spruce Resources Inc. (TSX VENTURE:SSE)(FRANKFURT:S6Q) (“Silver Spruce” or the [...]
HPQ Announces that Pyrogenesis has Issued an Update on the PUREVAP(TM) Project
MONTRÉAL, QUÉBEC–(Marketwired – March 14, 2018) – HPQ Silicon Resources Inc. (HPQ) (TSX VENTURE:HPQ)(FRANKFURT:UGE)(OTC PINK:URAGF) is pleased to inform shareholders [...]
Acasti Pharma Announces First Patient Randomized in Pivotal TRILOGY Phase 3 Program of CaPre in Severe Hypertriglyceridemia
LAVAL, QUÉBEC–(Marketwired – March 14, 2018) – Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST) today announced that the first patient has been […]
